Search

everythinglearnresearchcommunity

for

Search:↓

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Blocking RANK signaling might help treat metastatic melanoma, but more research is needed.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

Thymic LCH may be underdiagnosed, so thymic ultrasound should be considered in infants with cutaneous LCH.

Moles may stop growing because of cell cooperation, not just because of aging cells.

Moles may stop growing due to cell cooperation, not just because of individual cell aging.

The document concludes that understanding nail anatomy is key for diagnosing nail diseases, early signs of nail melanoma may allow for less aggressive treatment, and specific genetic mutations are important in thyroid cancer prognosis and treatment.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

Keratinocytes can reduce the survival of certain melanoma cells, suggesting new therapy paths.

BAP1 mutations are rare in pediatric melanocytic tumors and may develop later in life.

Keratinocytes can reverse the effects of the GNAQ oncogene, inhibiting melanoma cell growth.

The microenvironment affects the behavior and survival of melanocytes with the GNAQ oncogene in melanoma.

Scalp melanoma is more common and easier to diagnose early in people with androgenetic alopecia due to sun damage.

The environment around melanocyte stem cells is key for hair regeneration and color, with certain injuries affecting hair color and potential treatments for pigmentation disorders.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Researchers found that hair follicle stem cells can become squamous cell carcinoma due to Ras activation, which could lead to new treatments.

RET mutation is important in familial medullary thyroid carcinoma, and BRAF mutation in papillary thyroid carcinoma is linked to more aggressive cancer and higher death rates.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Immune cells boost stem cell activity in hairy moles, causing more hair growth.

UVB is good for a skin condition in Asian kids, a lotion works for head lice, a drug helps with a skin blistering disorder, a foam reduces itchiness in skin inflammation, birthmarks can be more widespread, and criteria for a neurocutaneous disorder were agreed upon.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Sorafenib after liver surgery may increase survival for some liver cancer patients.

Biological therapy boosts the immune system to effectively fight melanoma.

Non-scarring hair loss can be diagnosed with two 4mm punch biopsies, one cut vertically and the other transversely.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.